Antibodies: Engineering and Therapeutics

Antibodies, also called immunoglobulins, are large Y-shaped proteins which function to identify and help remove foreign antigens or targets such as viruses and bacteria. Antibodies are produced by specialized white blood cells called B lymphocytes (or B cells). When an antigen binds to the B-cell surface, it stimulates the B cell to divide and mature into a group of identical cells called a clone. The mature B cells, called plasma cells, secrete millions of antibodies into the bloodstream and lymphatic system. Every different antibody recognizes a specific foreign antigen. This is because the two tips of its “Y” are specific to each antigen, allowing different antibodies to bind to different foreign antigens.Antibodies are produced by the immune system in response to the presence of an antigen. Antigens are large molecules, usually proteins, on the surface of cells, viruses, fungi, bacteria, and some non-living substances such as toxins, chemicals, and foreign particles. Any substance capable of triggering an immune response is called an antigen. The antibody recognizes a unique molecule of the harmful agent, called an antigen, via the variable region.

 

 Antibody engineering has become a well-developed discipline, encompassing discovery methods, production strategies, and modification techniques that have brought forth clinically investigated and marketed therapeutics. The realization of the long-standing goal of production of fully human monoclonal antibodies has focused intensive research on the clinical employment of this potent drug category.

 

  • Lymphocytes: Research and novel strategies
  • Antibodies and neuroscience
  • Antibodies and neuroscience
  • Antibodies and neuroscience
  • Monoclonal antibodies and organ cancers
  • Antibodies and infectious diseases
  • Antibody biology & engineering
  • Antibodies as drugs: Immunological scaffolds as therapeutics
  • Antibody-targeted fusion proteins for cancer therapy
  • Genetics and epigenetics of the immune system
  • Genomic, metabolomic and proteomic advances in cancer immunotherapy

Antibodies: Engineering and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in